Correlation Study on the Expression of INSR, IRS-1, and PD-L1 in Nonsmall Cell Lung Cancer
Journal of Oncology · 04.10.2022 · 2022 · 1-7
DOI: 10.1155/2022/5233222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oncology, erschienen am 04.10.2022. Verfasst von Ma Ting und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, 271000 Shandong Province, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical and Health Science and Technology Development Project of Shandong Province.
Abstract (Originalsprache)
Objective
To study the expression and correlation of insulin receptor (INSR), insulin receptor substrate-1 (IRS-1), and programmed cell death ligand-1 (PD-L1) in nonsmall cell lung cancer (NSCLC).
Methods
45 lung cancer tissues and 30 adjacent normal tissues of NSCLC patients diagnosed in the Second Affiliated Hospital of Shandong First Medical University from June 2019 to August 2020 were selected. The expressions of INSR, IRS-1, and PD-L1 proteins in tumor tissues and adjacent tissues of NSCLC were detected by immunohistochemical staining.
Results
The expression of INSR and IRS-1 in NSCLC was significantly higher than that in adjacent normal lung tissue ( P < 0.05 ). INSR expression had statistical significance with the degree of pathological differentiation of nonsmall cell carcinoma ( P = 0.031 ), but had no significant association with age, gender, pathological type, TNM stage, and lymph node metastasis status ( P > 0.05 ). There was no significant correlation between IRS-1 positive expression and NSCLC patients’ age, gender, pathological typing, degree of differentiation, TNM stage, and lymph node metastasis ( P > 0.05 ). PD-L1 positive expression was correlated with lymph node metastasis of NSCLC ( P = 0.028 ), while there was no significant correlation with gender, age, pathological type, TNM stage, and pathological differentiation degree of NSCLC patients ( P > 0.05 ). Spearman correlation analysis showed that PD-L1 protein expression had a significant positive correlation with IRS-1 protein expression ( r = 0.373 ), but was not correlated with the expression of INSR protein.
Conclusion
IRS-1 may be involved in the regulation of PD-L1 expression and mediate the occurrence of tumor immune escape, which is expected to become a new target for NSCLC immunotherapy and provide new clinical evidence for immunosuppressive therapy.
Autor:innen und Institutionen
- Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, 271000 Shandong Province, China.
- The Second Affiliated Hospital of Shandong First Medical University, Tai'an, 271000 Shandong Province, China.
- Department of Chemotherapy, The Second Affiliated Hospital of Shandong First Medical University, Tai'an 271000, Shandong Province, China.
- Basic Medical College, Shandong First Medical University and Shandong Academy of Medical Sciences, Tai'an, 271000 Shandong Province, China.
- Department of Radiation Oncology, The Second Affiliated Hospital of Shandong First Medical University, Tai'an 271000, Shandong Province, China.
ORCID-Profile: Ma Ting, Guo-Qing Zhang, Jin Chang
Förderung
- Medical and Health Science and Technology Development Project of Shandong Province
Zitieren
APA
Ting, M., Miao, Y. E., Yu, F. X., Luo, G. C., Xu, X., Xiao, L. X., Zhang, G. Q., & Chang, J. (2022). Correlation Study on the Expression of INSR, IRS-1, and PD-L1 in Nonsmall Cell Lung Cancer. Journal of Oncology, 2022, 1-7. https://doi.org/10.1155/2022/5233222
Vancouver
Ting M, Miao YE, Yu FX, Luo GC, Xu X, Xiao LX, et al. Correlation Study on the Expression of INSR, IRS-1, and PD-L1 in Nonsmall Cell Lung Cancer. Journal of Oncology. 2022;2022:1-7. doi:10.1155/2022/5233222
BibTeX
@article{Ting2022,
author = {Ting, Ma and Miao, Yu-E and Yu, Feng-Xiu and Luo, Guang-Cai and Xu, Xin and Xiao, Li-Xia and Zhang, Guo-Qing and Chang, Jin},
title = {Correlation Study on the Expression of INSR, IRS-1, and PD-L1 in Nonsmall Cell Lung Cancer},
journal = {Journal of Oncology},
year = {2022},
volume = {2022},
pages = {1--7},
doi = {10.1155/2022/5233222}
}
EUVIMED